Why Molecular Templates (MTEM) Stock Is Down 60%
Why Molecular Templates (MTEM) Stock Is Down 60%
Trading of Molecular Templates' common stock is set to be suspended on December 26. The company says it does not intend to appeal Nasdaq's decision, and delisting will be formalized with the U.S. Securities and Exchange Commission following the suspension.Molecular Templates Inc (NASDAQ:MTEM) shares are trading lower by 60% to 13 cents during Friday's session after the company announced it received a Nasdaq delisting notice.
Molecular Templates Inc（納斯達克：MTEM）股票在週五交易時段下跌60%，至13美分，此前該公司宣佈收到納斯達克退市通知。
What To Know: Molecular Templates, a clinical-stage biopharmaceutical company developing cancer therapies, announced it has received notice from Nasdaq regarding the delisting of its securities.
需要了解的事項：Molecular Templates是一家臨牀階段生物製藥公司，專注於癌症治療，宣佈已收到納斯達克關於其證券退市的通知。
The Nasdaq Listing Qualifications Department cited the company's classification as a "public shell" and its failure to comply with key listing requirements. These include not filing its quarterly report for the third-quarter 2024 and failing to maintain the minimum $1.00 bid price for its stock.
納斯達克上市資格部門提到該公司的分類爲"公衆殼公司"，並且未能符合主要上市要求。這些要求包括未在2024年第三季度提交季度報告，並未能維持股票的最低買盤價1.00美元。
Trading of Molecular Templates' common stock is set to be suspended on December 26. The company says it does not intend to appeal Nasdaq's decision, and delisting will be formalized with the U.S. Securities and Exchange Commission following the suspension.
Molecular Templates的普通股交易將於12月26日暫停。該公司表示不打算對納斯達克的決定提出上訴，退市將在暫停後正式通知美國證券交易委員會。
Read Also: Fed's Preferred Inflation Gauge Falls More Than Expected: Markets Breathe Sigh Of Relief
另請閱讀：聯儲局首選的通脹指標下降幅度超過預期：市場鬆了一口氣。
According to data from Benzinga Pro, MTEM has a 52-week high of $4.12 and a 52-week low of $0.30.
根據Benzinga Pro的數據，MTEM的52周高點爲4.12美元，52周低點爲0.30美元。
譯文內容由第三人軟體翻譯。
